Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4405 results

Sort By:

PLatform for Adaptive Trials In Perinatal UnitS - [Core Protocol]

Study ID: NCT06461429
Start Date: 2025-02-01
End Date: 2050-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100000

Intervention / Treatment

Erythromycin

Amoxicillin and Erythromycin

Azithromycin

Caffeine citrate: Low dose

Caffeine citrate: Medium dose

Caffeine citrate: High dose

Sponsor

University of Melbourne

Source: clinicaltrials.gov

Share:
Add to list

Aligning Facility Leadership and Climate to Advance Mental Health Services Integration in Malawi

Study ID: NCT06399991
Start Date: 2025-04-01
End Date: 2027-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1080

Intervention / Treatment

Champion strategy

Adapted LOCI leadership and climate alignment strategy plus champion strategy

Sponsor

University of North Carolina, Chapel Hill

Source: clinicaltrials.gov

Share:
Add to list

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

Study ID: NCT06260891
Start Date: 2025-11
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

34

Intervention / Treatment

25 mg/day zinc

40 mg/day zinc

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

Study in Patients With Breast Cancer Leptomeningeal Metastasis

Study ID: NCT06638294
Start Date: 2024-12
End Date: 2028-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment
Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

Ridge Preservation Following Tooth Extraction

Study ID: NCT05485194
Start Date: 2025-12-01
End Date: 2028-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Reducing dimensional changes following tooth extraction

Sponsor

University of Maryland, Baltimore

Source: clinicaltrials.gov

Share:
Add to list

A Study to Learn How Different Tablets of the Study Medicine Mevrometostat Are Taken up Into the Blood in Healthy Adults

Study ID: NCT06661694
Start Date: 2024-12-16
End Date: 2025-04-29
Study Type

Interventional

Study Phase

Phase1

No. of Participants

16

Intervention / Treatment

Treatment A

Treatment B

Treatment C

Treatment D

Sponsor

Pfizer

Source: clinicaltrials.gov

Share:
Add to list

MCRcI® Stem Cell Treatment for Diffuse Coronary Artery Disease

Study ID: NCT04052191
Start Date: 2025-12-01
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

MCRcI® stem cells

Sponsor

Honya Medical Services

Source: clinicaltrials.gov

Share:
Add to list

Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis

Study ID: NCT06699394
Start Date: 2024-12-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Teclistamab (Tec)

Sponsor

Peking University People's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Investigation to Understand and Optimize Psilocybin

Study ID: NCT06512194
Start Date: 2025-02
End Date: 2029-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

141

Intervention / Treatment

Psilocybin

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)

Sham taVNS

Treatment as Usual

Sponsor

Elaine Sandler

Source: clinicaltrials.gov

Share:
Add to list

Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS

Study ID: NCT06692491
Start Date: 2025-01-01
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

Albumin-Bound Paclitaxel

Epirubicin

Gemcitabine

Vinorelbine

Cisplatin

Irinotecan

Fluorouracil

Nivolumab

Pembrolizumab

Durvalumab

Atezolizumab

Shintilimab

Tislelizumab

Camrelizumab

triplimab

Serplulimab

Adebrelimab

envafolimab

Osimertinib

Alectinib

Vemurafenib

On the sidelines

Pyrotinib

Imatinib

Palbociclib

I asked

Entrectinib

Other

Sponsor

Peking University Shenzhen Hospital

Source: clinicaltrials.gov

Share:
Add to list